|
|
Office Locations:
|
200 Broadhollow Rd, Ste 207
Melville, NY 11747
Phone: 212-808-2460
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Broadfin Capital is a global equity healthcare manager founded in 2005. Broadfin seeks to achieve mid-teen percent net returns through the consistent application of a value-oriented investment strategy based on deep, fundamental research. Drawing on its extensive research and investment experience in the medical technology, pharmaceuticals and biotechnology sectors, Broadfin's approach is differentiated by its ability to invest across all market capitalizations, a conservative approach to managing binary event risk, and focus on long-term returns.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
